CDXS PEER ANALYSIS

Codexis Inc — metric-by-metric comparison with peers and the industry median

CDXSCodexis Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
CDXSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
CDXS-12.1%MSB+27.6%RTALB+24.1%TLX-29.5%
Year-to-Date (YTD)
CDXS+51.5%MSB-24.3%RTALB+5.0%TLX+50.7%

Key Metric Comparison

P/E

Lower is better
CDXSMSBRTALB4.89TLXMedian 17.91

ROE

Higher is better
CDXS-68.9%MSB-11.3%RTALB15.1%TLX-1.8%Median -47.5%

Net Margin

Higher is better
CDXS-41.0%MSB-115.3%RTALB136.3%TLX-0.9%Median -125.7%

Revenue Growth

Higher is better
CDXS56.8%MSB410.4%RTALB24.0%TLX56.3%Median 5.1%

All Metrics

Valuation
MetricCDXSMSBRTALBTLXInd. Median
P/E4.8917.91
P/B5.190.616.373.51
EV/EBITDA74.61120.1414.82
P/S2.8731.616.673.2410.89
Financial Health
MetricCDXSMSBRTALBTLXInd. Median
Current Ratio5.361.211.435.90
Debt/Equity168.6%1.2%112.3%10.9%
NetDebt/EBITDA-0.330.9013.131.15
Profitability
MetricCDXSMSBRTALBTLXInd. Median
Net Margin-41.0%-115.3%136.3%-0.9%-125.7%
ROE-68.9%-11.3%15.1%-1.8%-47.5%
ROA-24.8%-8.6%13.1%-0.7%-35.8%
EBITDA Margin-28.2%-76.6%9.0%3.0%-105.8%
Growth + Dividend
MetricCDXSMSBRTALBTLXInd. Median
Rev. Growth56.8%410.4%24.0%56.3%5.1%
NI Growth134.0%12.1%
Div. Yield0.0%0.0%0.2%
Payout0.0%0.0%0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CDXS

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.